These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28422784)

  • 21. Plasma IL-5 but Not CXCL13 Correlates With Neutralization Breadth in HIV-Infected Children.
    Roider J; Porterfield JZ; Ogongo P; Muenchhoff M; Adland E; Groll A; Morris L; Moore PL; Ndung'u T; Kløverpris H; Goulder PJR; Leslie A
    Front Immunol; 2019; 10():1497. PubMed ID: 31333650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Broadly Neutralizing Antibodies Against HIV: New Insights to Inform Vaccine Design.
    Sadanand S; Suscovich TJ; Alter G
    Annu Rev Med; 2016; 67():185-200. PubMed ID: 26565674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses.
    Locci M; Havenar-Daughton C; Landais E; Wu J; Kroenke MA; Arlehamn CL; Su LF; Cubas R; Davis MM; Sette A; Haddad EK; ; Poignard P; Crotty S
    Immunity; 2013 Oct; 39(4):758-69. PubMed ID: 24035365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of circulatory Tfh-like cells with neutralizing antibody responses among chronic HIV-1 subtype C infected long-term nonprogressors and progressors.
    Swathirajan CR; Nandagopal P; Vignesh R; Srikrishnan AK; Goyal R; Qureshi H; Saravanan S; Solomon SS; Hanna LE; Sivasankaran MP; Singla N; Mukherjee J; Chatrath S; Kopycinski J; Murugavel KG
    Pathog Dis; 2019 Jun; 77(4):. PubMed ID: 31505637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-1 antibodies in prevention of transmission.
    Barin F; Braibant M
    Curr Opin HIV AIDS; 2019 Jul; 14(4):273-278. PubMed ID: 30973417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Broadly Neutralizing Antibodies as Treatment: Effects on Virus and Immune System.
    Bhiman JN; Lynch RM
    Curr HIV/AIDS Rep; 2017 Apr; 14(2):54-62. PubMed ID: 28349376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reconstitution and characterization of antibody repertoires of HIV-1-infected "elite neutralizers".
    Sun Z; Li J; Hu X; Shao Y; Zhang MY
    Antiviral Res; 2015 Jun; 118():1-9. PubMed ID: 25770672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immune Effects and Mechanisms of HIV-specific Antibodies Against Viral Infection].
    Su B; Li L; Mou D; Moog C; Wu H; Zhang T
    Bing Du Xue Bao; 2016 Nov; 32(6):830-8. PubMed ID: 30004659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory Antibodies.
    Zhang Z; Li S; Gu Y; Xia N
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host controls of HIV broadly neutralizing antibody development.
    Kelsoe G; Haynes BF
    Immunol Rev; 2017 Jan; 275(1):79-88. PubMed ID: 28133807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Broadly neutralizing antibodies for treatment and prevention of HIV-1 infection.
    Cohen YZ; Caskey M
    Curr Opin HIV AIDS; 2018 Jul; 13(4):366-373. PubMed ID: 29697469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccinal effect of HIV-1 antibody therapy.
    Naranjo-Gomez M; Pelegrin M
    Curr Opin HIV AIDS; 2019 Jul; 14(4):325-333. PubMed ID: 30973419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress in HIV-1 antibody research using humanized mice.
    Gruell H; Klein F
    Curr Opin HIV AIDS; 2017 May; 12(3):285-293. PubMed ID: 28422792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Chronic HIV/SIV Infection on T Follicular Helper Cell Subsets and Germinal Center Homeostasis.
    Graff-Dubois S; Rouers A; Moris A
    Front Immunol; 2016; 7():501. PubMed ID: 27891132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens.
    Hessell AJ; Malherbe DC; Pissani F; McBurney S; Krebs SJ; Gomes M; Pandey S; Sutton WF; Burwitz BJ; Gray M; Robins H; Park BS; Sacha JB; LaBranche CC; Fuller DH; Montefiori DC; Stamatatos L; Sather DN; Haigwood NL
    J Immunol; 2016 Apr; 196(7):3064-78. PubMed ID: 26944928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 Transmission.
    Gombos RB; Kolodkin-Gal D; Eslamizar L; Owuor JO; Mazzola E; Gonzalez AM; Korioth-Schmitz B; Gelman RS; Montefiori DC; Haynes BF; Schmitz JE
    J Virol; 2015 Aug; 89(15):7813-28. PubMed ID: 25995259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Towards HIV-1 remission: potential roles for broadly neutralizing antibodies.
    Halper-Stromberg A; Nussenzweig MC
    J Clin Invest; 2016 Feb; 126(2):415-23. PubMed ID: 26752643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dysfunction of T follicular helper cells.
    Cubas R; Perreau M
    Curr Opin HIV AIDS; 2014 Sep; 9(5):485-91. PubMed ID: 25023620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Germinal center enhancement by extended antigen availability.
    Cirelli KM; Crotty S
    Curr Opin Immunol; 2017 Aug; 47():64-69. PubMed ID: 28738289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological Fingerprints of Controllers Developing Neutralizing HIV-1 Antibodies.
    Martin-Gayo E; Gao C; Chen HR; Ouyang Z; Kim D; Kolb KE; Shalek AK; Walker BD; Lichterfeld M; Yu XG
    Cell Rep; 2020 Jan; 30(4):984-996.e4. PubMed ID: 31995767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.